/
Unless the context otherwise requires, we , us , and our , the Company and PAVmed refer to PAVmed Inc. and its subsidiaries, including its subsidiary Lucid Diagnostics Inc. (Nasdaq:LUCD) ( Lucid Diagnostics or Lucid ) and its majority-owned subsidiary Veris Health Inc. ( Veris Health or Veris ). Background and Overview PAVmed is a diversified commercial-stage life sciences company operating in …
The business is unprofitable at the operating level (-30712.68% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 97.6% YoY. Margins deteriorated 29229.8pp alongside, both lines moving the wrong way.
Negative free cash flow of -$5M. The business is consuming cash, not generating it. Operating margin contracted 29229.8pp YoY, cost discipline may be slipping.
Profitability & Returns
Revenue (TTM)
$85K
▼ -97.6% YoY
Net Income (TTM)
-$19M
▼ -99.0% YoY
Op. Margin
-28700.00%
▼ -29229.8pp YoY
ROIC
-45.97%
▲ +876.5pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$6M
▲ +84.4% YoY
Op. Cash Flow (TTM)
-$6M
▲ +84.5% YoY
Net Debt
$11M
Cash & Equiv.
$6M
3Y CAGR: -42.7%
Continue Research